Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1CNS 1

Conditions

Gliosarcoma 12Glioblastoma 12Sarcoma 10Central Nervous System Neoplasms 8Astrocytoma 8Brain Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Large B-Cell, Diffuse 6Lymphoma, Follicular 6Lymphoma, B-Cell, Marginal Zone 6Lymphoma 6Leukemia, Lymphocytic, Chronic, B-Cell 6Burkitt Lymphoma 6Recurrence 5Oligodendroglioma 5Hodgkin Disease 5Glioma 5Dendritic Cell Sarcoma, Interdigitating 5Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Leukemia 4Familial ependymoma 4Ependymoma 4Rhabdomyosarcoma 3Primary Myelofibrosis 3Osteosarcoma 3Neoplasm Metastasis 3

Interventions

Doxorubicin 25Gemcitabine 16Trabectedin 12Ifosfamide 12Radiotherapy 11Docetaxel 10Dacarbazine 8pazopanib 7Nivolumab 6Specimen Handling 5Biopsy 5liposomal doxorubicin 4Temozolomide 4pembrolizumab 3Sunitinib 3Sorafenib 3Radiation 3Magnetic Resonance Spectroscopy 3Filgrastim 3rucaparib 2pegfilgrastim 2olaratumab 2eribulin 2durvalumab 2cixutumumab 2cemiplimab 2brostallicin 2belinostat 2avelumab 2X-Rays 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leiomyosarcoma × sargramostim × Sarcoma × Clear all
NCT00069940 2010-12-28

Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Dana-Farber Cancer Institute

Phase 1 Completed
CNSGastrointestinalSarcoma

Familial ependymoma, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Leiomyosarcoma, Liposarcoma, Oligodendroglioma, Sarcoma, Sarcoma, Synovial, Central Nervous System Neoplasms, Gliosarcoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡